Craniofacial tissue engineering offers promising solutions for addressing large bone defects caused by congenital abnormalities,trauma,or disease.Traditional approaches,such as autografts and synthetic materials,are w...Craniofacial tissue engineering offers promising solutions for addressing large bone defects caused by congenital abnormalities,trauma,or disease.Traditional approaches,such as autografts and synthetic materials,are widely used but face limitations,including donor site morbidity,immune rejection,and poor graft integration.Recent advancements in biomaterials,including nanoscale scaffold design,bioceramics,cell-laden hydrogels,and bioactive modifications,present promising strategies to replicate the biological,mechanical,and structural properties of native bone.This review explores innovative strategies to enhance osteoconductivity,osteoinductivity,and osteogenicity of engineered grafts,including the use of advanced biomaterials,immunomodulatory scaffolds,and bioprinting technologies.Key biological challenges are discussed alongside translational barriers.Future directions emphasize the integration of bioprinted,vascularized,multiphasic tissues,alongside personalized therapies and advanced fabrication techniques,to accelerate clinical adoption.By bridging nanoscale innovations with the demands of large-scale clinical application,this review outlines pathways toward scalable,personalized,and clinically effective solutions to restore functionality and aesthetics in craniofacial reconstruction.展开更多
基金NIH/NCI/NIDCR funding under Grant(Nos.R01DE026170,R01DE029553,R21CA263860,and T90DE030859)the Friends of Doernbecher Grant Program at OHSU,the Osteo Science Foundation,the Department of Defense(W81XWH-15-9-0001)the OHSU Silver Family Innovation Award.
文摘Craniofacial tissue engineering offers promising solutions for addressing large bone defects caused by congenital abnormalities,trauma,or disease.Traditional approaches,such as autografts and synthetic materials,are widely used but face limitations,including donor site morbidity,immune rejection,and poor graft integration.Recent advancements in biomaterials,including nanoscale scaffold design,bioceramics,cell-laden hydrogels,and bioactive modifications,present promising strategies to replicate the biological,mechanical,and structural properties of native bone.This review explores innovative strategies to enhance osteoconductivity,osteoinductivity,and osteogenicity of engineered grafts,including the use of advanced biomaterials,immunomodulatory scaffolds,and bioprinting technologies.Key biological challenges are discussed alongside translational barriers.Future directions emphasize the integration of bioprinted,vascularized,multiphasic tissues,alongside personalized therapies and advanced fabrication techniques,to accelerate clinical adoption.By bridging nanoscale innovations with the demands of large-scale clinical application,this review outlines pathways toward scalable,personalized,and clinically effective solutions to restore functionality and aesthetics in craniofacial reconstruction.
